Crossmark

The business case for cell and gene therapies

Crossref DOI link: https://doi.org/10.1038/nbt.3084

Published Online: 2014-12-09

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abou-El-Enein, Mohamed

Bauer, Gerhard

Reinke, Petra
License Information

Text and Data Mining valid from 2014-12-01
More Information

Article History

First Online: 9 December 2014

Competing interests

: The authors declare no competing financial interests.